Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Revenue: 2017-2024

Historic Revenue for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $258.0 million.

  • Arcus Biosciences' Revenue fell 45.83% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year decrease of 8.75%. This contributed to the annual value of $258.0 million for FY2024, which is 120.51% up from last year.
  • Arcus Biosciences' Revenue amounted to $258.0 million in FY2024, which was up 120.51% from $117.0 million recorded in FY2023.
  • Arcus Biosciences' Revenue's 5-year high stood at $383.0 million during FY2021, with a 5-year trough of $78.0 million in FY2020.
  • For the 3-year period, Arcus Biosciences' Revenue averaged around $162.3 million, with its median value being $117.0 million (2023).
  • As far as peak fluctuations go, Arcus Biosciences' Revenue skyrocketed by 420.00% in 2020, and later crashed by 70.76% in 2022.
  • Yearly analysis of 5 years shows Arcus Biosciences' Revenue stood at $78.0 million in 2020, then skyrocketed by 391.03% to $383.0 million in 2021, then plummeted by 70.76% to $112.0 million in 2022, then rose by 4.46% to $117.0 million in 2023, then soared by 120.51% to $258.0 million in 2024.